Dr. Lal Pathlabs Profit & Loss Annual

Trade
BSE: 539524 | NSE: LALPATHLAB | ISIN: INE600L01024 | Sector: Healthcare Facilities
3,086.55 +28.80 (0.94%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 2,226.602,016.882,087.411,581.27
Total Revenue 2,226.602,016.882,087.411,581.27
Costof Revenue Total 451.40473.06524.37415.89
Gross Profit 1,775.201,543.821,563.041,165.38
Selling/ General/ Admin Expenses Total 737.501,016.91962.59699.12
Depreciation/ Amortization 143.60150.19108.1177.20
Other Operating Expenses Total 428.4037.0837.8129.81
Total Operating Expense 1,760.901,677.241,632.881,222.01
Operating Income 465.70339.64454.53359.25
Interest Inc( Exp) Net- Non- Op Total -294.0037.07204.51330.41
Other Net 69.20-0.330.602.29
Net Income Before Taxes 505.50343.83474.98394.41
Provisionfor Income Taxes 143.20102.75124.6997.93
Net Income After Taxes 362.30241.08350.29296.48
Minority Interest -4.60-2.23-5.46-4.86
Net Income Before Extra Items 357.70238.85344.83291.62
Net Income 357.70238.85344.83291.62
Income Availableto Com Excl Extra Ord 357.70238.85344.83291.62
Income Availableto Com Incl Extra Ord 357.70238.85344.83291.62
Diluted Net Income 357.70238.85344.83291.62
Diluted Weighted Average Shares 8.328.318.298.27
Diluted EPS Excluding Extra Ord Items 42.9828.7441.5735.25
DPS- Common Stock Primary Issue 24.0012.0012.0020.00
Diluted Normalized EPS 42.9828.6741.6335.26
Gain( Loss)on Saleof Assets -8.07-6.00-1.74
Dilution Adjustment --0.00-
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts